In hepatocellular carcinoma, WDR4 interacts with the translation initiation factor EIF2A to promote the translation of CCNB1 and thus promote proliferation, metastasis and sorafenib resistance [16]. This evidence concerns the gene EIF2A and hepatocellular carcinoma.